259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
Precancerous model of human breast epithelial cells induced by NNK for prevention
Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity
Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death
Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen
Sentinel node biopsy in patients with multiple breast cancer
BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women
SSRI use and breast cancer risk by hormone receptor status
NSAID use and breast cancer risk in the VITAL cohort
Parity and disparity in first course treatment of invasive breast cancer
The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques
10
47
48
49
51
111
3114
3115
3116
3117
3118
23
41
1007
2091
3039
3054
5055
6082
29
1102
6047
6082
"No Shows"